Field Guide · Deconstructed
When a PANS kid flushes, breaks out in hives, reacts to half their food, spirals into anxiety, and reacts to the supplements meant to help — the mast cell is often the thread tying it together. Here are the facts: what MCAS actually is, the exact tests an MCAS doctor runs, and what treatment really looks like (the layered “MCAS cocktail,” step by step). Plus who’s a credible specialist, and how to vet a practitioner. Choose your own adventure from here.
I walked this part of the labyrinth myself — knocked on the doors, read the research, and came back with the map. You don’t have to find the way out alone.
This addresses mast-cell / histamine activation. When over-firing mast cells are genuinely the driver, the anxiety, irritability, flushing, GI reactivity, the “wired and tired” state, and the reactivity to foods and supplements tend to ease as the mast cells are stabilized. The honest caveat: only testing — the timed mediator workup below — tells you whether this is actually your child’s driver (and mast cells usually fire because of a deeper root).
The antihistamines and stabilizers below plug the hole and make life livable — and a good MCAS specialist is excellent at exactly that. But mast cells fire for a reason. They’re almost always reacting to a root driver lighting them up — chronic infection (Lyme / Bartonella is the classic), mold / mycotoxins, or gut dysbiosis.
So: plug the hole to stabilize — then go find the root. Treating only the MCAS is bailing water while the boat keeps filling; the only thing that makes mast cells truly calm is treating what set them off. You often need two people — an MCAS doctor for the calm, and a Lyme/functional doctor for the leak — and almost no one sits between them connecting it. That gap is exactly what Minta closes.
It can take a long time to realize the patch isn’t the cure. This is so you don’t lose that time.
Mast Cell Activation Syndrome (MCAS) is when mast cells — the body’s frontline immune sentries — fire inappropriately, dumping their chemical payload when they shouldn’t. Mast cells line the skin, gut, airways, and the lining of blood vessels, and when they degranulate they release a cocktail of mediators: histamine, tryptase, prostaglandins (PGD2), leukotrienes, and heparin, among others. In MCAS that release is chronic and out of proportion to any real threat.
Because mast cells are everywhere, the symptoms are multisystem and migrating — which is exactly why MCAS gets missed for years. The classic picture:
MCAS is one of the core PANS overlaps. Mast cells sit at the crossroads of the immune system and the brain — they release histamine and inflammatory mediators that directly drive anxiety, irritability, and the neuro-inflammation that fuels a flare. A reactive, mast-cell-primed child is a child whose nervous system is being chemically poked all day. It’s also why so many PANS kids react to their own treatment — the fillers and excipients in a supplement, a new food, a die-off — can each trip an already-twitchy mast cell. Calm the mast cells and you often lower the whole reactivity floor the rest of the protocol has to work over. Histamine is itself a neurotransmitter; mast-cell mediators cross into and inflame the nervous system. Source: Using the Right Criteria for MCAS (PMC).
This is the workup, laid out clearly. The hard truth up front: MCAS is largely a clinical diagnosis — the labs support it but rarely “prove” it, because mediators are released in bursts and degrade fast. The single validated rule is tryptase measured in a flare versus the child’s own baseline. A good MCAS doctor casts a wider net than that, and times the draws to a reaction.
| Test | What it measures / why | Note |
|---|---|---|
| Serum tryptase baseline + flare | The validated marker. Draw a baseline when well, then a second within ~1–4 hours of a flare. A real, transient rise above the child’s own baseline is the strongest objective evidence. | Highest value |
| Plasma histamine | Histamine released into the blood during activation. Very short half-life — must be drawn fast and kept chilled, or it’s falsely normal. | Timing-sensitive |
| Whole-blood histamine | Total histamine load. This is also the Walsh histadelia marker — elevated whole-blood histamine flags undermethylation, the bridge between the MCAS picture and the methylation engine. Walsh’s normal band is roughly 40–70 ng/mL. | Also a methylation read |
| 24-hr urine N-methylhistamine | The stable breakdown product of histamine. Because it’s a metabolite collected over a day, it’s more reliable than a single blood histamine — it doesn’t vanish in minutes. | More reliable than plasma |
| 24-hr urine PGD2 prostaglandin D2 / 11β-PGF2α | Prostaglandin D2 (measured as its stable metabolite 2,3-dinor-11β-PGF2α) is mast-cell-specific and often the most sensitive marker when tryptase is unrevealing. | Often the catch |
| 24-hr urine leukotriene E4 | The stable end-product of the leukotriene arm — the mediator class that drives airway and inflammatory symptoms. Elevated across all MCAS subtypes. | Adds the leukotriene arm |
| Chromogranin A | A broader mast-cell / neuroendocrine mediator; helps when the histamine and prostaglandin markers are borderline (interpret off PPIs, which raise it). | Supporting |
| DAO diamine oxidase | The enzyme that clears histamine in the gut. Low DAO points to histamine intolerance — a related “can’t-break-it-down” problem that often rides alongside MCAS. | The intolerance angle |
ARUP Consult — Mast Cell Disorders test selection · Mayo — Mast Cell Mediators, 24-hr urine · Improved identification: tryptase + 24-hr 11β-PGF2α (JACI: In Practice) · Walsh whole-blood histamine / histadelia.
Before settling on MCAS, a careful doctor rules out clonal mast-cell disease (mastocytosis) — a different, more serious condition where the body makes too many abnormal mast cells. The screen:
The widely-used consensus criteria need all three: (1) recurrent symptoms in two or more organ systems; (2) an event-related rise in a mast-cell mediator — the validated one being serum tryptase climbing to at least 120% of baseline + 2 ng/mL during a flare; and (3) a documented response to mast-cell-targeted treatment. Notice the third criterion: the treatment response is itself part of the diagnosis. That’s why a careful trial of the cocktail below isn’t just therapy — it’s diagnostic. Source: Using the Right Criteria for MCAS (PMC) · Reversible tryptase elevation as the best biomarker (PMC).
This is the heart of it: what MCAS doctors actually DO. Treatment is a ladder, not a single pill. You build it up one layer at a time, and most stable patients end up on a combination — the “MCAS cocktail.” The whole thing rests on one rule for reactive kids: start low, go slow, change one variable at a time. A mast-cell kid can react to the filler in a tablet, so the order and pacing matter as much as the drug.
| Rung | What it is | Examples |
|---|---|---|
| 1 · Avoidance + diet | Always first. Identify and remove triggers; trial a low-histamine diet (and reduce histamine-liberating foods). This is the foundation everything else sits on. | Low-histamine diet, trigger log, fragrance/heat/stress management |
| 2 · H1 antihistamine | Blocks histamine at the H1 receptor — skin, neuro, vascular. Taken daily as a baseline, not just for reactions. | Cetirizine, loratadine, fexofenadine; hydroxyzine (more sedating, useful at night) |
| 3 · H2 antihistamine | Blocks the H2 receptor — gut and stomach. Layered on top of the H1, not instead of it. (H1 + H2 together is the core pairing.) | Famotidine |
| 4 · Mast-cell stabilizer | Stops the mast cell from degranulating in the first place. Cromolyn works mostly in the gut (poorly absorbed — that’s the point for GI symptoms); ketotifen is absorbed body-wide and is itself an H1 blocker. | Cromolyn sodium (oral), ketotifen |
| 5 · Leukotriene blocker | Shuts down the leukotriene arm — airway, inflammatory, and some GI symptoms the antihistamines don’t reach. | Montelukast |
| 6 · Natural stabilizers | Flavonoids that stabilize mast cells and lower histamine release — gentle, often well-tolerated add-ons (watch fillers). | Quercetin, luteolin, vitamin C |
| 7 · DAO enzyme | For the histamine-intolerance piece — supplemental diamine oxidase taken with meals to help break down dietary histamine in the gut. | DAO supplement (with food) |
| 8 · Step-up (refractory) | When the cocktail above isn’t enough, specialists escalate. | Low-dose aspirin (targets PGD2), omalizumab / Xolair (anti-IgE biologic), low-dose naltrexone (LDN) |
Gaudiani Clinic — Fundamentals of treating MCAS · EDS Clinic — cromolyn vs ketotifen · Mast Attack — MCAS treatment.
The MCAS cocktail isn’t one rung — it’s the layered combination most stable patients land on:
H1 + H2 + mast-cell stabilizer + leukotriene blocker
You add them one at a time, holding each long enough to read the effect, so that if the child reacts you know exactly which one did it. That’s the whole logic of going slow — not timidity, but signal. And because mast-cell kids famously react to fillers and excipients, the cleanest formulation (sometimes compounded) can matter as much as the molecule.
Start low, go slow, one variable at a time. A child whose mast cells are already primed will react harder and to smaller things — so the dose you’d use in an adult is often the dose that flares the kid. Tiny starting doses, single changes, and patience are how you find the cocktail without setting off the very system you’re trying to calm.
One of the most respected MCAS clinicians in the US. MD/PhD from the University of Pennsylvania; Internal Medicine and Allergy & Immunology training at Brigham and Women’s and Mount Sinai; board-certified in both Allergy & Immunology and Internal Medicine. She sits on the scientific/medical faculty of The Mast Cell Disease Society and the Ehlers-Danlos Society’s international consortium — the two organizations at the center of this field — and her clinical focus is squarely on diagnosing and treating mast-cell activation disease.
Where she practices now: she is Medical Director of Comprehensive Allergy & Asthma Care (Tarrytown, NY) and an Assistant Professor at the Icahn School of Medicine at Mount Sinai. Note: she was previously at the Metrodora Institute in Salt Lake City — but Maitland left Metrodora in early 2025 and the institute closed its clinical operations in July 2025, so that affiliation is no longer current. We’ve updated it here to her present practice.
She reportedly takes insurance — verify directly before assuming it, but if so it’s a meaningful deal, because most dedicated MCAS care is cash-pay. We list her as a credible reference point, not an outcome endorsement: a name to know in a field with few real experts, not a promise of results. Sources: The Mast Cell Disease Society — Anne Maitland, MD, PhD · The Ehlers-Danlos Society — Anne Maitland · Comprehensive Allergy & Asthma Care · The Sick Times — Metrodora closure.
Start at the top and follow your child. Tap to open.
If symptoms span two or more systems (skin + gut + neuro, say) and flare unpredictably — MCAS is on the table. The tell that clinches it for many PANS families: the child reacts to the very supplements meant to help. Move to the workup ↓
Baseline tryptase when well, then flare tryptase within ~1–4 hrs. Add 24-hr urine N-methylhistamine, PGD2, and leukotriene E4, plus plasma/whole-blood histamine, chromogranin A, and DAO. Rule OUT mastocytosis (baseline tryptase >20, KIT D816V).
Remember the third criterion: response to treatment is part of the diagnosis. Start the ladder: low-histamine diet → H1 → H2 → stabilizer (cromolyn/ketotifen) → montelukast, layering one at a time. A clear improvement is itself evidence.
Start lower than you think. Use the cleanest formulations (compounded if needed to dodge fillers), add the natural stabilizers (quercetin/luteolin/vitamin C) and DAO with meals, and change one thing at a time. This is the whole reason MCAS care goes slowly.
This is the refractory step-up — with a specialist: low-dose aspirin (for the PGD2 flushers), omalizumab (Xolair), or low-dose naltrexone. A name to know in this field: Dr. Anne Maitland (above).
This is a lot — and you don’t have to read it alone. Minta takes your child’s mediator panel, ties it to their daily symptoms, food reactions, and the rest of their labs (including the methylation/histamine link), and helps you build the cocktail one careful rung at a time — the start-low-go-slow plan no single visit has time to walk with you. Let Minta do this with you →
Credentials, polish, and how conventional an approach sounds tell you little about whether a practitioner will help your child — or harm them. What does: their behavior and their incentives. Watch those.
MCAS is a real, consensus-defined condition — but it’s also become a catch-all that some practitioners over-diagnose and monetize. Don’t judge by the label; judge the conduct and the incentives.
MCAS is mast cells firing when they shouldn’t, spraying histamine and other mediators across every system — and for a PANS kid it’s often the hidden driver of the reactivity, the food intolerance, and the can’t-tolerate-the-treatment problem. The workup is real but timing-dependent: tryptase in a flare vs. baseline, plus the 24-hr urine mediators (N-methylhistamine, PGD2, leukotriene E4), with mastocytosis ruled out. And the treatment is a ladder you climb slowly — diet, then H1 + H2 + stabilizer + leukotriene blocker, with natural stabilizers, DAO, and a refractory step-up behind it. The diagnosis and the treatment are the same act: a careful, one-variable-at-a-time trial. This is parent education, not medical advice — bring it to your team as questions.
Plan B does not partner with drug companies or doctors, and we never endorse anyone whose healing isn’t verified by families. We show you the options and how to vet them yourself — and we’re building parent verification: look up a practitioner and see real family reviews before you trust them. Universal bad reviews? Skip.